News & Alerts
-
Oct- 2023 -6 October
Federal Judge Approves Class Action for North Carolinians Affected by Toxic Water Pollution
In a significant legal development, U.S. District Judge James Dever in Raleigh has granted approval for more than 100,000 residents…
Read More » -
6 October
WHO Warns of Dengue Fever Surge in Southern United States, Europe, and Africa Due to Climate Change
Dengue fever, a tropical disease transmitted by Aedes aegypti mosquitoes, is poised to become a significant threat in regions where…
Read More » -
5 October
UniQure to Implement 20% Workforce Reduction in Major Restructuring Move
Dutch gene therapy company uniQure N.V. has announced a significant restructuring plan aimed at cost-saving measures. As part of this…
Read More » -
4 October
Roche’s Evrysdi Achieves Remarkable Milestone in SMA Treatment for Pre-Symptomatic Babies
In a groundbreaking development, Roche has unveiled highly positive results from the primary analysis of the ongoing RAINBOWFISH study, which…
Read More » -
4 October
AstraZeneca Settles Lawsuits Over Heartburn Drugs for $425 Million in Landmark Agreement
AstraZeneca, the British pharmaceutical giant, has reached a significant settlement in the United States to pay $425 million in order…
Read More » -
4 October
Boehringer Ingelheim Launches Highly Affordable Unbranded Humira Biosimilar
German pharmaceutical company Boehringer Ingelheim has made a major move in the biosimilar market by introducing an unbranded version of…
Read More » -
4 October
Kaiser Permanente Faces Labor Clash as Healthcare Workers Threaten Largest Strike in U.S. Medical Industry
Kaiser Permanente, a prominent healthcare network and managed-care organization, appeared to be on the brink of a significant labor conflict…
Read More » -
2 October
FDA Denies Approval for Eli Lilly’s Eczema Treatment Drug
The U.S. Food and Drug Administration (FDA) has made a decision not to approve Eli Lilly’s drug, which was intended…
Read More » -
2 October
Viatris Announces Strategic Divestitures Totaling $3.6 Billion
On Sunday, pharmaceutical company Viatris announced that it has reached agreements to divest several of its business segments, totaling up…
Read More » -
2 October
Cigna and the U.S. Government Agree on a $172 Million Medicare Advantage Overbilling Settlement
Health insurer Cigna Group has recently reached a settlement with the United States government concerning allegations that it overcharged the…
Read More »